NRC Health (National Research Corporation) - 10-Q Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended June 30, 2003, for National Research Corporation (NRC Health). The company provides performance measurement services for healthcare organizations. A significant business development during this period was the acquisition of Smaller World Communications Inc. (SWC) in March 2003, expanding operations into Canada.
Key Financial Metrics
| Metric | Three Months Ended June 30, 2003 | Six Months Ended June 30, 2003 |
|---|---|---|
| Revenues | $6,128,692 | $12,186,559 |
| Net Income | $907,991 | $1,828,586 |
| Operating Income | $1,445,802 | $2,958,095 |
| Net Cash from Operating Activities | N/A | $4,779,009 |
| Cash and Cash Equivalents (End of Period) | $2,698,477 | $2,698,477 |
| Working Capital | $13,855,929 | $13,855,929 |
| Total Debt (Notes Payable) | $5,109,394 | $5,109,394 |
| Operating Margin | 23.6% | 24.3% |
| Effective Tax Rate | 37.2% | 37.5% |
Material Changes vs. Prior Period
- Revenue Growth: Revenues increased 27.7% for the quarter and 37.7% for the six-month period compared to the prior year. This growth was driven by new clients, specifically a major contract with the Ontario Hospital Association (adding ~$796,000 in Q2 revenue) and the U.S. Department of Veterans Affairs.
- Expense Increases: Direct expenses rose 49.9% (Q/Q) and 53.4% (YTD) due to incremental costs of servicing new clients, including higher printing, postage, and labor costs. Selling, general, and administrative (SG&A) expenses increased 40.9% (Q/Q) and 19.3% (YTD), partly due to a $100,000 bad debt expense and higher marketing/salary costs.
- Profitability: Despite higher expenses, Net Income increased 1.4% for the quarter and 53.7% for the six-month period. Operating margins improved slightly year-over-year for the six-month period (24.3% vs 23.6%) but declined for the quarter (23.6% vs 31.5%) due to the mix of services and HealthSouth-related events.
- Acquisition Impact: The acquisition of SWC added $1.2 million in goodwill and $218,000 in customer relationships. Pro forma results indicate the acquisition contributed to the revenue growth.
Guidance, Outlook, and Risks
- Outlook: Management expects direct expenses as a percentage of revenue to increase slightly in Q3 due to the delivery of the Healthcare Market Guide but decrease in Q4 to align with annual margin expectations. SG&A expenses are expected to decrease as a percentage of revenue for the remainder of 2003. The effective tax rate is projected to range between 37% and 38% for the balance of the year.
- Capital Resources: The company maintains strong liquidity with $2.7 million in cash and $13.9 million in working capital. Cash flow from operations was robust at $4.8 million for the six months ended June 30, 2003.
- Stock Repurchases: In July 2003, the Board authorized a new repurchase program for 500,000 shares. As of August 1, 2003, no shares had been repurchased under this new authorization, though 70,500 shares were repurchased under a prior 1999 authorization.
- Risks/Contingencies: The filing notes a modification of a contract with HealthSouth Corporation reported in June 2003. Additionally, the company recorded $100,000 in bad debt expenses, indicating potential credit risk exposure.
Key Facts for Investor Verification
- Revenue Quality: Verify the sustainability of revenue from the new Ontario Hospital Association and VA contracts, which drove the majority of the 37.7% YTD revenue increase.
- Expense Mix: Monitor the trend of direct expenses as a percentage of revenue, which rose to 45.0% YTD, to ensure it returns to historical norms in Q4 as management predicts.
- Acquisition Integration: Assess the performance of the newly acquired Smaller World Communications Inc. against the revenue goals tied to the contingent purchase price payments.
- Bad Debt Exposure: Investigate the specific nature of the $100,000 bad debt expense recorded in SG&A to understand potential future credit risks.
- Deferred Revenue: Note the $4.8 million in billings in excess of revenues earned (deferred revenue), representing a significant backlog of work to be recognized in future periods.